Envoy Medical (COCH) Operating Margin (2022 - 2026)
Envoy Medical (COCH) reported Operating Margin of 15279.49% for Q1 2026, down 417731.0% on a YoY basis from N/an in Q1 2025, and down 79.48% sequentially from 8513.33% in Q4 2025.
Envoy Medical (COCH) Operating Margin (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of Operating Margin data on file, last reported at 15279.49% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 417731.0% year-over-year to 15279.49%; the trailing twelve-month figure through Mar 2026 stood at 9881.2% (down 69252.0% YoY), and the FY2025 full-year result was 9240.66%, down 68244.0% from the prior year.
- Operating Margin declined to 15279.49% in Q1 2026, from 8513.33% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 3150.88% in Q3 2022 to a low of 15279.49% in Q1 2026.
- A 5-year average of 8736.2% and a median of 8277.97% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin surged 745316 bps in 2023 and plunged 471190 bps in 2025, its largest moves.
- Tracing COCH's Operating Margin over 5 years: stood at 14530.0% in 2022, then surged by 51 bps to 7076.84% in 2023, then sank by 53 bps to 10830.95% in 2024, then advanced by 21 bps to 8513.33% in 2025, then plunged by 79 bps to 15279.49% in 2026.
- Business Quant data shows COCH's Operating Margin at 15279.49% in Q1 2026, 8513.33% in Q4 2025, and 13590.48% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 6.17% |
| 10 | Envoy Medical | 46.48 Mn | 21.23 Mn | -274,000.00 | -15,279.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,279.49% |
| Dec 31, 2025 | -8,513.33% |
| Sep 30, 2025 | -13,590.48% |
| Jun 30, 2025 | -6,500.00% |
| Mar 31, 2025 | -11,102.17% |
| Dec 31, 2024 | -10,830.95% |
| Sep 30, 2024 | -8,878.57% |
| Jun 30, 2024 | -7,135.29% |
| Mar 31, 2024 | -8,277.97% |
| Dec 31, 2023 | -7,076.84% |
| Sep 30, 2023 | -4,231.25% |
| Jun 30, 2023 | -7,111.11% |
| Mar 31, 2023 | -4,834.62% |
| Dec 31, 2022 | -14,530.00% |
| Sep 30, 2022 | -3,150.88% |